These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sarcoglycan complex: a muscular supporter of dystroglycan-dystrophin interplay? Matsumura K, Saito F, Yamada H, Hase A, Sunada Y, Shimizu T. Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):751-62. PubMed ID: 10541473 [Abstract] [Full Text] [Related]
3. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies. Matsumura K, Campbell KP. Muscle Nerve; 1994 Jan; 17(1):2-15. PubMed ID: 8264699 [Abstract] [Full Text] [Related]
4. Interactions between dystrophin and the sarcolemma membrane. Chamberlain JS, Corrado K, Rafael JA, Cox GA, Hauser M, Lumeng C. Soc Gen Physiol Ser; 1997 Jan; 52():19-29. PubMed ID: 9210217 [Abstract] [Full Text] [Related]
5. Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Lim LE, Duclos F, Broux O, Bourg N, Sunada Y, Allamand V, Meyer J, Richard I, Moomaw C, Slaughter C. Nat Genet; 1995 Nov; 11(3):257-65. PubMed ID: 7581448 [Abstract] [Full Text] [Related]
6. Cardiomyopathy is independent of skeletal muscle disease in muscular dystrophy. Zhu X, Wheeler MT, Hadhazy M, Lam MY, McNally EM. FASEB J; 2002 Jul; 16(9):1096-8. PubMed ID: 12039854 [Abstract] [Full Text] [Related]
7. Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses. Côté PD, Moukhles H, Lindenbaum M, Carbonetto S. Nat Genet; 1999 Nov; 23(3):338-42. PubMed ID: 10610181 [Abstract] [Full Text] [Related]
8. A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor-regulated channel. Iwata Y, Katanosaka Y, Arai Y, Komamura K, Miyatake K, Shigekawa M. J Cell Biol; 2003 Jun 09; 161(5):957-67. PubMed ID: 12796481 [Abstract] [Full Text] [Related]
9. Dystroglycan and muscular dystrophies related to the dystrophin-glycoprotein complex. Sciandra F, Bozzi M, Bianchi M, Pavoni E, Giardina B, Brancaccio A. Ann Ist Super Sanita; 2003 Jun 09; 39(2):173-81. PubMed ID: 14587215 [Abstract] [Full Text] [Related]
10. Deficiency of the 50 kDa dystrophin-associated-glycoprotein (adhalin) in an Indian autosomal recessive limb girdle muscular dystrophy patient : immunochemical analysis and clinical aspects. Handa V, Mital A, Gupta M, Goyle S. Neurol India; 2001 Mar 09; 49(1):19-24. PubMed ID: 11303236 [Abstract] [Full Text] [Related]
11. Sequential expression of genes involved in muscular dystrophies during human development. Durand M, Suel L, Barbet JP, Beckmann JS, Fougerousse F. Morphologie; 2002 Jun 09; 86(273):9-12. PubMed ID: 12224393 [Abstract] [Full Text] [Related]
12. [Clinicopathological characteristics and molecular genetics of adhalin deficiency (severe childhood autosomal recessive muscular dystrophy/SCARMD)]. Matsumura K. Nihon Rinsho; 1997 Dec 09; 55(12):3154-8. PubMed ID: 9436427 [Abstract] [Full Text] [Related]
13. Extraocular muscle is spared despite the absence of an intact sarcoglycan complex in gamma- or delta-sarcoglycan-deficient mice. Porter JD, Merriam AP, Hack AA, Andrade FH, McNally EM. Neuromuscul Disord; 2001 Mar 09; 11(2):197-207. PubMed ID: 11257478 [Abstract] [Full Text] [Related]
14. Epsilon-sarcoglycan compensates for lack of alpha-sarcoglycan in a mouse model of limb-girdle muscular dystrophy. Imamura M, Mochizuki Y, Engvall E, Takeda S. Hum Mol Genet; 2005 Mar 15; 14(6):775-83. PubMed ID: 15689353 [Abstract] [Full Text] [Related]
15. Specific assembly pathway of sarcoglycans is dependent on beta- and delta-sarcoglycan. Shi W, Chen Z, Schottenfeld J, Stahl RC, Kunkel LM, Chan YM. Muscle Nerve; 2004 Mar 15; 29(3):409-19. PubMed ID: 14981741 [Abstract] [Full Text] [Related]
16. Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex. Hack AA, Lam MY, Cordier L, Shoturma DI, Ly CT, Hadhazy MA, Hadhazy MR, Sweeney HL, McNally EM. J Cell Sci; 2000 Jul 15; 113 ( Pt 14)():2535-44. PubMed ID: 10862711 [Abstract] [Full Text] [Related]
17. [Gamma-sarcoglycanopathy: clinico-pathological and genetic study of 11 cases]. García-García D, Teijeira-Bautista S, Fernández-Rodríguez JM, Flores-Calvete J, Sánchez-Espíldora P, Fernández-Couto D, Cimas-Hernando I, Teijeiro-Ferreira A, Fernández-Hojas R, Brasa-Fernández Fierros J, Martínez de Alegría A, Escribano-Arias JL, Núñez-Delgado M, Navarro-Fernández Balbuena C. Rev Neurol; 1998 Jun 15; 26(154):905-11. PubMed ID: 9658457 [Abstract] [Full Text] [Related]
18. Localization of sarcoglycan, neuronal nitric oxide synthase, beta-dystroglycan, and dystrophin molecules in normal skeletal myofiber: triple immunogold labeling electron microscopy. Wakayama Y, Inoue M, Kojima H, Murahashi M, Shibuya S, Oniki H. Microsc Res Tech; 2001 Nov 01; 55(3):154-63. PubMed ID: 11747090 [Abstract] [Full Text] [Related]
19. [The frequency of patients with adhalin deficiency in a muscular dystrophy patient population]. Hayashi YK, Arahata K. Nihon Rinsho; 1997 Dec 01; 55(12):3165-8. PubMed ID: 9436429 [Abstract] [Full Text] [Related]
20. A 5' dystrophin duplication mutation causes membrane deficiency of alpha-dystroglycan in a family with X-linked cardiomyopathy. Bies RD, Maeda M, Roberds SL, Holder E, Bohlmeyer T, Young JB, Campbell KP. J Mol Cell Cardiol; 1997 Dec 01; 29(12):3175-88. PubMed ID: 9441825 [Abstract] [Full Text] [Related] Page: [Next] [New Search]